The real advantage of the Wearable Artificial Kidney, according to the people behind it, is that it would allow patients to mobilize while still being treated, giving them chance to go to places such as work or school. After multiple tests overseas, Dr. Victor Gura and researchers from UCLA are set to run their first clinical trial here in the US later this year, which will bring it one step closer to becoming a commercial product. Once that's done, it will be up to the Food and Drug Administration to determine if it can give it a seal of approval.